vs
Side-by-side financial comparison of SELECT MEDICAL HOLDINGS CORP (SEM) and Tapestry, Inc. (TPR). Click either name above to swap in a different company.
Tapestry, Inc. is the larger business by last-quarter revenue ($2.5B vs $1.4B, roughly 1.8× SELECT MEDICAL HOLDINGS CORP). Tapestry, Inc. runs the higher net margin — 22.4% vs 1.4%, a 21.0% gap on every dollar of revenue. On growth, Tapestry, Inc. posted the faster year-over-year revenue change (14.0% vs 6.4%). Tapestry, Inc. produced more free cash flow last quarter ($1.0B vs $5.2M). Over the past eight quarters, Tapestry, Inc.'s revenue compounded faster (29.9% CAGR vs 2.8%).
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
Tapestry, Inc. is a leading American multinational luxury fashion holding company. It owns three iconic lifestyle brands: Coach, Kate Spade New York, and Stuart Weitzman, offering premium handbags, apparel, footwear, accessories, and fragrances to global consumers via physical retail stores and e-commerce platforms.
SEM vs TPR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $2.5B |
| Net Profit | $20.2M | $561.3M |
| Gross Margin | — | 75.5% |
| Operating Margin | 4.6% | 28.6% |
| Net Margin | 1.4% | 22.4% |
| Revenue YoY | 6.4% | 14.0% |
| Net Profit YoY | 225.7% | 80.8% |
| EPS (diluted) | $0.17 | $2.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | $2.5B | ||
| Q3 25 | $1.4B | $1.7B | ||
| Q2 25 | $1.3B | $1.7B | ||
| Q1 25 | $1.4B | $1.6B | ||
| Q4 24 | $1.3B | $2.2B | ||
| Q3 24 | $1.3B | $1.5B | ||
| Q2 24 | $1.3B | $1.6B | ||
| Q1 24 | $1.3B | $1.5B |
| Q4 25 | $20.2M | $561.3M | ||
| Q3 25 | $28.8M | $274.8M | ||
| Q2 25 | $40.6M | $-517.1M | ||
| Q1 25 | $56.7M | $203.3M | ||
| Q4 24 | $-16.1M | $310.4M | ||
| Q3 24 | $55.6M | $186.6M | ||
| Q2 24 | $77.6M | $159.3M | ||
| Q1 24 | $96.9M | $139.4M |
| Q4 25 | — | 75.5% | ||
| Q3 25 | — | 76.3% | ||
| Q2 25 | — | 76.3% | ||
| Q1 25 | — | 76.1% | ||
| Q4 24 | — | 74.4% | ||
| Q3 24 | — | 75.3% | ||
| Q2 24 | — | 74.9% | ||
| Q1 24 | — | 74.7% |
| Q4 25 | 4.6% | 28.6% | ||
| Q3 25 | 5.4% | 19.3% | ||
| Q2 25 | 6.5% | -33.9% | ||
| Q1 25 | 8.3% | 16.0% | ||
| Q4 24 | 1.6% | 22.4% | ||
| Q3 24 | 4.3% | 16.7% | ||
| Q2 24 | 5.8% | 14.8% | ||
| Q1 24 | 9.0% | 13.8% |
| Q4 25 | 1.4% | 22.4% | ||
| Q3 25 | 2.1% | 16.1% | ||
| Q2 25 | 3.0% | -30.0% | ||
| Q1 25 | 4.2% | 12.8% | ||
| Q4 24 | -1.2% | 14.1% | ||
| Q3 24 | 4.4% | 12.4% | ||
| Q2 24 | 6.1% | 10.0% | ||
| Q1 24 | 7.3% | 9.4% |
| Q4 25 | $0.17 | $2.68 | ||
| Q3 25 | $0.23 | $1.28 | ||
| Q2 25 | $0.32 | $-2.30 | ||
| Q1 25 | $0.44 | $0.95 | ||
| Q4 24 | $-0.12 | $1.38 | ||
| Q3 24 | $0.43 | $0.79 | ||
| Q2 24 | $0.60 | $0.67 | ||
| Q1 24 | $0.75 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $26.5M | $1.1B |
| Total DebtLower is stronger | $1.8B | $2.4B |
| Stockholders' EquityBook value | $1.7B | $551.2M |
| Total Assets | $5.9B | $6.5B |
| Debt / EquityLower = less leverage | 1.06× | 4.32× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.5M | $1.1B | ||
| Q3 25 | $60.1M | $743.2M | ||
| Q2 25 | $52.3M | $1.1B | ||
| Q1 25 | $53.2M | $1.1B | ||
| Q4 24 | $59.7M | $1.0B | ||
| Q3 24 | $191.5M | $7.3B | ||
| Q2 24 | $111.2M | $7.2B | ||
| Q1 24 | $92.6M | $7.4B |
| Q4 25 | $1.8B | $2.4B | ||
| Q3 25 | $1.7B | $2.4B | ||
| Q2 25 | $1.8B | $2.4B | ||
| Q1 25 | $1.8B | $2.4B | ||
| Q4 24 | $1.7B | $2.4B | ||
| Q3 24 | $3.1B | $7.0B | ||
| Q2 24 | $3.6B | $6.9B | ||
| Q1 24 | $3.8B | $7.7B |
| Q4 25 | $1.7B | $551.2M | ||
| Q3 25 | $1.7B | $399.5M | ||
| Q2 25 | $1.7B | $857.8M | ||
| Q1 25 | $1.7B | $1.5B | ||
| Q4 24 | $1.7B | $1.3B | ||
| Q3 24 | $1.9B | $3.0B | ||
| Q2 24 | $1.4B | $2.9B | ||
| Q1 24 | $1.4B | $2.8B |
| Q4 25 | $5.9B | $6.5B | ||
| Q3 25 | $5.7B | $6.4B | ||
| Q2 25 | $5.7B | $6.6B | ||
| Q1 25 | $5.7B | $7.3B | ||
| Q4 24 | $5.6B | $7.3B | ||
| Q3 24 | $8.0B | $13.7B | ||
| Q2 24 | $7.9B | $13.4B | ||
| Q1 24 | $7.9B | $13.7B |
| Q4 25 | 1.06× | 4.32× | ||
| Q3 25 | 1.03× | 5.95× | ||
| Q2 25 | 1.10× | 2.77× | ||
| Q1 25 | 1.03× | 1.59× | ||
| Q4 24 | 1.01× | 1.78× | ||
| Q3 24 | 1.62× | 2.35× | ||
| Q2 24 | 2.54× | 2.39× | ||
| Q1 24 | 2.75× | 2.77× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $64.3M | $1.1B |
| Free Cash FlowOCF − Capex | $5.2M | $1.0B |
| FCF MarginFCF / Revenue | 0.4% | 41.5% |
| Capex IntensityCapex / Revenue | 4.2% | 1.7% |
| Cash ConversionOCF / Net Profit | 3.19× | 1.93× |
| TTM Free Cash FlowTrailing 4 quarters | $117.2M | $1.6B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $64.3M | $1.1B | ||
| Q3 25 | $175.3M | $112.6M | ||
| Q2 25 | $110.3M | $446.8M | ||
| Q1 25 | $-3.5M | $144.3M | ||
| Q4 24 | $125.4M | $506.0M | ||
| Q3 24 | $181.0M | $119.5M | ||
| Q2 24 | $278.2M | $256.0M | ||
| Q1 24 | $-66.7M | $97.8M |
| Q4 25 | $5.2M | $1.0B | ||
| Q3 25 | $122.2M | $80.2M | ||
| Q2 25 | $45.6M | $411.5M | ||
| Q1 25 | $-55.8M | $113.4M | ||
| Q4 24 | $62.0M | $475.1M | ||
| Q3 24 | $130.3M | $93.9M | ||
| Q2 24 | $222.6M | $209.8M | ||
| Q1 24 | $-119.2M | $78.8M |
| Q4 25 | 0.4% | 41.5% | ||
| Q3 25 | 9.0% | 4.7% | ||
| Q2 25 | 3.4% | 23.9% | ||
| Q1 25 | -4.1% | 7.2% | ||
| Q4 24 | 4.7% | 21.6% | ||
| Q3 24 | 10.2% | 6.2% | ||
| Q2 24 | 17.4% | 13.2% | ||
| Q1 24 | -9.0% | 5.3% |
| Q4 25 | 4.2% | 1.7% | ||
| Q3 25 | 3.9% | 1.9% | ||
| Q2 25 | 4.8% | 2.0% | ||
| Q1 25 | 3.9% | 2.0% | ||
| Q4 24 | 4.8% | 1.4% | ||
| Q3 24 | 4.0% | 1.7% | ||
| Q2 24 | 4.3% | 2.9% | ||
| Q1 24 | 4.0% | 1.3% |
| Q4 25 | 3.19× | 1.93× | ||
| Q3 25 | 6.09× | 0.41× | ||
| Q2 25 | 2.72× | — | ||
| Q1 25 | -0.06× | 0.71× | ||
| Q4 24 | — | 1.63× | ||
| Q3 24 | 3.25× | 0.64× | ||
| Q2 24 | 3.59× | 1.61× | ||
| Q1 24 | -0.69× | 0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SEM
| Critical Illness Recovery Hospitals | $629.7M | 45% |
| Health Care Patient Service Non Medicare | $428.6M | 31% |
| Rehabilitation Hospitals | $339.2M | 24% |
TPR
| Coach | $1.4B | 57% |
| Other | $787.0M | 31% |
| Kate Spade Company | $290.0M | 12% |
